MedTrace Logo

Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

NCT06234501 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-11

No results posted yet for this study

Summary

This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.

Conditions

Interventions

DIETARY_SUPPLEMENT

Pyridoxal 5'-Phosphate (100 mg)

100 mg Pyridoxal 5'-Phosphate tablet once daily with food

OTHER

Placebo

Placebo tablet once daily

Sponsors & Collaborators

  • INNOPURE

    collaborator UNKNOWN

  • University of Reading

    lead OTHER

Principal Investigators

  • Dr David T Field, PhD · University of Reading

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-08
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06234501 on ClinicalTrials.gov